v1
Phase II study of daily oral etoposide plus ifosfamide plus cisplatin for previously treated recurrent small-cell lung cancer: a Hoosier Oncology Group Trial.
Identifier:nobleid.org/w1/20260515/F2FC2C66
Type:Journal Article
0 views
Embeddable Badge
[](https://nobleid.org/work/w1/20260515/F2FC2C66)
Bibliometric Analysis
Impact metrics, research fronts, co-authorship networks →
Authors & Claims